Study of the Tranexamic Acid Influence on Blood Loss in Arthroplasty

被引:0
|
作者
Predescu, Vlad [1 ]
Jinescu, George [2 ]
Olaru, Razvan Ionut [3 ]
Prescura, Catalin [3 ]
Deleanu, Bogdan [4 ]
机构
[1] Carol Davila Univ Med & Pharm, 8 Eroii Sanitari Str, Bucharest 050474, Romania
[2] Floreasca Teaching Emergency Hosp, 8 Calea Floreasca, Bucharest 014461, Romania
[3] St Pantelimon Teaching Emergency Hosp, 340-342 Pantelimon Rd, Bucharest 021659, Romania
[4] Victor Babes Univ Med & Pharm, 2 Eftimie Murgu Sq, Timisoara 300041, Romania
来源
REVISTA DE CHIMIE | 2016年 / 67卷 / 08期
关键词
tranexamic acid; total knee replacement; total hip replacement; blood loss;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Within the period 2010-2012, a prospective study has been conducted in order to examine the blood-saving effect of the tranexamic acid (TXA) in total knee (TKA) and hip arthroplasty. There were 100 TKA, 50 total hip replacements. A total of 3.000 mg/30 mL TXA + 60 ml saline solution has been injected intra-articular at closure into the knee joint through a closed suction drain and then the tourniquet was released. In hip joint, the injection was performed at the end of the skin closure. Then the drain was closed for 6 hours and then activated. Total blood loss was calculated from the maximum loss of hemoglobin (Hb). The hemoglobin levels, the volumes from drainage and pre- and post-operatively leg diameters (thigh, suprapatellar portion and calf girth) have been analyzed post-operatively. All patients were followed clinically to detect presence of venous thromboembolism (VTE). The results revealed that post-operative decrease in Hb level was significantly reduced after tranexamic injection (1.7 units), whereas the need for postoperative blood transfusion decreasedby 90%.The mean postoperatively blood loss in drainage was 150m (50- 325mL). Furthermore, knee joint swelling after operation was significantly reduced. There wasn't any systemic reaction or clinical symptoms of deep venous thrombosis (DVT).
引用
收藏
页码:1513 / 1515
页数:3
相关论文
共 50 条
  • [1] Fibrinolysis and blood loss in major arthroplasty - the effect of tranexamic acid
    Benoni, G
    ACTA ORTHOPAEDICA SCANDINAVICA, 1997, 68 : 86 - 86
  • [2] Tranexamic acid for the reduction of blood loss in total knee arthroplasty
    Oremus, Kresimir
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3
  • [3] Tranexamic acid reduces blood loss after knee arthroplasty
    Howes, JP
    Sharma, V
    Cohen, AT
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1996, 78B (06): : 995 - 996
  • [4] Tranexamic acid reduces blood loss after knee arthroplasty - Reply
    Benoni, G
    Fredin, H
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1996, 78B (06): : 996 - 996
  • [5] The effect of tranexamic acid on hidden blood loss in total hip arthroplasty
    Akti, Sefa
    Zeybek, Hakan
    Bilekli, Ahmet Burak
    Celebi, Nilgun Ozgul
    Erdem, Yusuf
    Cankaya, Deniz
    JOINT DISEASES AND RELATED SURGERY, 2022, 33 (01): : 102 - 108
  • [6] Tranexamic Acid for Reduction of Blood Loss During Total Hip Arthroplasty
    Imai, Norio
    Dohmae, Yoichiro
    Suda, Ken
    Miyasaka, Dai
    Ito, Tomoyuki
    Endo, Naoto
    JOURNAL OF ARTHROPLASTY, 2012, 27 (10): : 1838 - 1843
  • [7] EFFICACY OF TRANEXAMIC ACID IN REDUCING BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY
    Sadigursky, David
    Araujo, Larissa Martins
    Carneiro Fernandes, Rogerio Jamil
    ACTA ORTOPEDICA BRASILEIRA, 2018, 26 (01): : 63 - 66
  • [8] Tranexamic acid decreases blood loss after total shoulder arthroplasty
    Friedman, Richard J.
    Gordon, Eric
    Butler, R. Bryan
    Mock, Lisa
    Dumas, Bonnie
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2016, 25 (04) : 614 - 618
  • [9] The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study
    Hynes, MC
    Calder, P
    Rosenfeld, P
    Scott, G
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2005, 87 (02) : 99 - 101
  • [10] Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study
    Lanoiselee, Julien
    Zufferey, Paul J.
    Ollier, Edouard
    Hodin, Sophie
    Delavenne, Xavier
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (02) : 310 - 319